Aetiology and outcomes of secondary myelofibrosis occurring in the context of inherited platelet disorders: A single institutional study of four patients

Br J Haematol. 2020 Sep;190(5):e316-e320. doi: 10.1111/bjh.16897. Epub 2020 Jun 22.

Authors

Affiliations

¹ Division of Hematology, Mayo Clinic, Rochester, MN, USA.
² Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
³ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
⁴ Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.

PMID: 32567678
DOI: 10.1111/bjh.16897

No abstract available

Keywords: G6B; Myelofibrosis; congenital thrombocytopenia; gray platelet syndrome; inherited platelet disorders.

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Adult
Amino Acid Substitution
Blood Platelet Disorders / complications
Blood Platelet Disorders / genetics*
Blood Proteins / genetics*
Female
Genetic Diseases, Inborn / complications
Genetic Diseases, Inborn / genetics*
Humans
Male
Middle Aged
Mutation, Missense*
Primary Myelofibrosis / etiology
Primary Myelofibrosis / genetics*

Substances

Blood Proteins
NBEAL2 protein, human